This inventor holds 1 USPTO granted patent. Top assignee: Rhode Island Council on Postsecondary Education. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Phyllis Losikoff: Innovator in Immunology
Introduction
Phyllis Losikoff is a notable inventor based in Sharon, MA (US). She has made significant contributions to the field of immunology, particularly in the development of pharmaceutical compositions aimed at suppressing immunity in animals.
Latest Patents
Phyllis Losikoff holds a patent for a regulatory T cell epitope and hepatitis C virus homolog. This innovative pharmaceutical composition comprises an isolated T-cell epitope peptide containing the amino acid sequence of PLLLLLXLPXRA (SEQ ID NO: 5), where X represents an amino acid. This invention is crucial for advancing treatments related to immune suppression.
Career Highlights
Losikoff is affiliated with the Rhode Island Council on Postsecondary Education, where she continues to contribute her expertise in immunology and pharmaceutical development. Her work has been instrumental in enhancing our understanding of immune responses and potential therapeutic interventions.
Collaborations
Throughout her career, Phyllis has collaborated with esteemed colleagues such as Stephen Owen Gregory and Anne DeGroot. These partnerships have fostered a collaborative environment that promotes innovation and research in the field.
Conclusion
Phyllis Losikoff's contributions to immunology through her patent and collaborative efforts highlight her role as a significant innovator in the field. Her work continues to influence advancements in pharmaceutical compositions aimed at immune suppression.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile